Akero Therapeutics, Inc.
AKRO
$54.63
-$0.06-0.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.69% | 0.31% | -1.00% | 3.69% | -29.86% |
| Total Depreciation and Amortization | -- | -- | -- | 1,400.00% | 0.00% |
| Total Amortization of Deferred Charges | -3.76% | 4.49% | 2.30% | 6.10% | 4.46% |
| Total Other Non-Cash Items | 25.64% | -1.48% | 56.97% | 5.46% | -25.48% |
| Change in Net Operating Assets | -60.56% | 534.83% | -159.61% | 23.00% | 73.79% |
| Cash from Operations | -39.23% | 28.70% | -0.86% | 4.73% | -22.58% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.43% | 116.45% | -3,257.30% | -79.10% | 128.67% |
| Cash from Investing | -28.43% | 116.45% | -3,257.30% | -79.10% | 128.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -1.81% | -99.13% | 421.06% | 2,327.98% | 857.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -1,886.21% | 54.69% | 86.58% |
| Cash from Financing | -1,091.17% | -99.13% | 420.50% | 2,377.70% | 2,144.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.64% | 122.37% | -738.38% | 323.35% | 101.82% |